Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12325
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEkinci, Elif Ien
dc.contributor.authorChiu, W-Len
dc.contributor.authorLu, Z Xen
dc.contributor.authorSikaris, Ken
dc.contributor.authorChurilov, Leoniden
dc.contributor.authorBittar, Ien
dc.contributor.authorLam, Qen
dc.contributor.authorCrinis, Nen
dc.contributor.authorHoulihan, Christine Aen
dc.date.accessioned2015-05-16T01:59:42Z
dc.date.available2015-05-16T01:59:42Z
dc.date.issued2014-10-02en
dc.identifier.citationClinical Endocrinology 2014; 82(4): 604-10en
dc.identifier.govdoc25079145en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12325en
dc.description.abstractThyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TGAb) are frequently measured to investigate thyroid dysfunction in pregnancy. Despite the recognized fall of these autoantibodies in pregnancy, there is limited guidance on the timing of such testing. We assessed optimal test timing of TPOAb/TGAb for the detection of Hashimoto's thyroiditis and post-partum thyroid dysfunction (PPTD).Prospective longitudinal study with recruitment in Trimester 1.Healthy women ≤13 weeks' gestation from Mercy Hospital for Women, a tertiary obstetric hospital in Melbourne.Serum TPOAb, TGAb, TSH and fT4 were measured at Trimester 1 (T1), Trimester 2(T2), Trimester 3(T3) and postpartum (PP) in each participant. Post-partum thyroid dysfunction (PPTD) was defined if TSH deviated from the assay's nonpregnant reference interval. Longitudinal random-effect logistic regression was used to investigate the association between time and positive/negative thyroid autoantibody status.Samples from 140 women at T1 (12·0: 10·3-13·0) (median: IQR weeks' gestation); 95 at T2 (24·3: 23·0-25·9), 79 at T3 (35·9: 34·8-36·7) and 83 at PP (12·4: 10·8-14·6 weeks post-partum) were attained. At T1, 13 (9%) and 15 (11%) women had positive TPOAb and TGAb, respectively. The odds of having a positive TPOAb were 96% lower at T2 [OR = 0·04 (95% CI: 0·02-0·8; P = 0·03)] and 97% lower at T3 [OR = 0·03 (95% CI: 0·001-0·6; P = 0·02)] than at T1. Similarly, the odds of having a positive TGAb were 99·4% lower [OR = 0·006 (95% CI: 0-0·3; P = 0·01)] at T2, and 99·5% lower [OR = 0·005 (95% CI: 0-0·4; P = 0·02)] at T3 than at T1. The ROC analysis diagnostic ORs for a positive TPOAb and/or TGAb to predict PPTD were 7·8 (95% CI: 2·2-27·6), 1·2 (95% CI: 0-8·9), 2·0 (95% CI: 0-16·8), and 12·2 (95% CI: 3·3-44·9) at T1, T2, T3 and post-partum, respectively.A significant proportion of pregnant women lose their thyroid autoantibody positivity after T1. The gestation-dependent loss of TPOAb/TGAb positivity and reduction in diagnostic accuracy for predicting PPTD limits the value of testing at T2 and T3.en
dc.language.isoenen
dc.titleA longitudinal study of thyroid autoantibodies in pregnancy: the importance of test timing.en
dc.typeJournal Articleen
dc.identifier.journaltitleClinical Endocrinologyen
dc.identifier.affiliationMenzies School of Health Research, Darwin, NT, Australiaen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Endocrinology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1111/cen.12571en
dc.description.pages604-10en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25079145en
dc.type.austinJournal Articleen
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Jun 22, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.